CDER’s Role in Public Health Emergency Response and Medical Countermeasure Development

Center for Drug Evaluation and Research (CDER) discusses how they execute emergency preparedness and response to public health incidents, including medical countermeasure (MCM) development programs, with highlights from both past public health emergencies and the current COVID-19 pandemic response.



Presenters:

Kelly Ngan, PharmD,

CDR, USPHS

Team Leader

Project Management and Emergency Coordination



Andrea Gormley, PharmD

LCDR, USPHS

Associate Director for Regulatory Affairs



Counter-Terrorism and Emergency Coordination Staff (CTECS)

Office of the Center Director, CDER



Learn More at: https://www.fda.gov/drugs/regulatory-...



_______________________________  
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.   

  

Upcoming Training - https://www.fda.gov/cdersbia

SBIA Listserv - https://public.govdelivery.com/accoun...

SBIA 2021 Playlist -    • 2021 CDER Small Business and Industry...  

SBIA LinkedIn -   / cder-small-business-and-industry-assistance  

SBIA Training Resources - https://www.fda.gov/cdersbialearn

Twitter -   / fda_drug_info  

Email - [email protected]

Phone - (301) 796-6707 I (866) 405-5367